| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 12,409 | 10,808 | 9,806 | 14,685 | | Cost of Revenue | 8,547 | 7,179 | 8,367 | 9,109 | | | Gross Profit | 3,862 | 3,629 | 1,439 | 5,576 | | | Operating Expenses | | Research Development | 1,411 | 1,898 | 1,977 | 2,135 | | Selling General and Administrative | 4,697 | 4,770 | 3,930 | 5,483 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,246) | (3,039) | (4,468) | (2,042) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 70 | (106) | 52 | 517 | | Earnings Before Interest And Taxes | (2,176) | (3,145) | (4,416) | (1,525) | | Interest Expense | 206 | 143 | 155 | 161 | | Income Before Tax | (2,382) | (3,288) | (4,571) | (1,686) | | Income Tax Expense | 238 | 198 | (17) | 474 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,620) | (3,486) | (4,554) | (2,160) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,620) | (3,486) | (4,554) | (2,160) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,620) | ($3,486) | ($4,554) | ($2,160) |
|
0.31% Nasdaq 
0.05%
Income Statement
